HAEMONETICS CORP's ticker is HAE and the CUSIP is 405024100. A total of 243 filers reported holding HAEMONETICS CORP in Q1 2022. The put-call ratio across all filers is 0.55 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $5,388,416 | +14.7% | 60,152 | +9.0% | 0.03% | +13.8% |
| Q2 2023 | $4,699,302 | -7.9% | 55,195 | -10.4% | 0.03% | -6.5% |
| Q1 2023 | $5,099,800 | +8.9% | 61,629 | +3.5% | 0.03% | +19.2% |
| Q4 2022 | $4,681,799 | -21.9% | 59,527 | -26.5% | 0.03% | -13.3% |
| Q3 2022 | $5,995,000 | +13.5% | 80,981 | -0.1% | 0.03% | +36.4% |
| Q2 2022 | $5,283,000 | +13.7% | 81,045 | +10.3% | 0.02% | +15.8% |
| Q1 2022 | $4,646,000 | +56.5% | 73,493 | +31.3% | 0.02% | +11.8% |
| Q4 2021 | $2,969,000 | -11.8% | 55,975 | +17.4% | 0.02% | -5.6% |
| Q3 2021 | $3,365,000 | -2.7% | 47,669 | -8.2% | 0.02% | -18.2% |
| Q2 2021 | $3,459,000 | – | 51,905 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Nitorum Capital, L.P. | 413,122 | $16,608,000 | 4.78% |
| Altalis Capital Management LLC | 88,055 | $3,540,000 | 3.97% |
| RUTABAGA CAPITAL MANAGEMENT LLC/MA | 513,619 | $20,647,000 | 3.54% |
| Black Creek Investment Management Inc. | 1,118,613 | $44,968,000 | 3.46% |
| HealthCor Management, L.P. | 1,150,000 | $46,230,000 | 2.61% |
| Van Berkom & Associates Inc. | 1,136,971 | $45,706,000 | 1.83% |
| AMERICAN CAPITAL MANAGEMENT INC | 567,896 | $22,829,000 | 1.77% |
| FULLER & THALER ASSET MANAGEMENT, INC. | 2,062,539 | $82,914,000 | 1.25% |
| Legato Capital Management LLC | 1,336 | $53,707,000 | 0.97% |
| HEARTLAND ADVISORS INC | 351,314 | $14,123,000 | 0.78% |